Background: Hypoxia is a prevalent pathological process in chronic rhinosinusitis with nasal polyps (CRSwNP), leading to a cascade of pathological events, including epithelial-mesenchymal transition (EMT). However, the mechanisms underlying hypoxia-induced EMT remain unclear. This study aims to elucidate the mechanisms driving EMT under hypoxic conditions in CRSwNP. Methods: Transcriptome and proteome analyses of hypoxia-treated human nasal epithelial cells (HNECs) were performed to identify key molecules and pathways. The expression of hypoxia-inducible factor-1 alpha (HIF-1 alpha), pyruvate dehydrogenase kinase (PDK1), lactate dehydrogenase A (LDHA), and EMT markers was assessed in nasal tissues from CRSwNP patients. In vitro, cultured HNECs were exposed to hypoxia and lactate, or overexpressed PDK1, to evaluate changes in EMT markers. Results: Hypoxia activated the glycolysis-related pathway in HNECs, with PDK1 and LDHA identified as significantly upregulated glycolysis-related enzymes. The expression of PDK1 and LDHA was closely correlated with HIF-1 alpha and EMT markers in nasal tissues. Hypoxia induced an increase in PDK1 and LDHA expression, lactate production, and EMT occurrence in HNECs. PDK1 overexpression or lactate stimulation also triggered EMT, while PDK1 inhibition attenuated hypoxia-induced EMT in HNECs. Conclusions: This study is the first to reveal that hypoxia-induced activation of PDK1 plays a critical role in regulating EMT by promoting lactate production, thereby providing a potential therapeutic target for CRSwNP.
基金:
The National Key R&D Program of China,
Grant/Award Number: 2022YFC2504100;
The Beijing New‐star Plan of Science and
Technology, Grant/Award Numbers:
20240484625, 20220484226; The Program
for Changjiang Scholars and Innovative
Research Team, Grant/Award Number:
IRT13082; The Natural Science Foundation of
Beijing, Grant/Award Number: 7222024; The
National Natural Science Foundation of China,
Grant/Award Number: 82171110; The CAMS
Innovation Fund for Medical Sciences, Grant/
Award Number: 2019‐I2M‐5–022; The Beijing
Municipal Science & Technology Commission,
Grant/Award Number: Z211100002921057;
The Capital's Funds for Health Improvement
and Research, Grant/Award Number: 2022‐1‐
1091; The Special Funds for the Construction
of High‐level Public Health Technical Talents,
Grant/Award Numbers: Lingjunrencai‐01‐08,
Lingjunrencai‐02‐09; The Beijing Municipal
Public Welfare Development and Reform Pilot
Project for Medical Research Institutes,Beijing Municipal Health Commission, Grant/
Award Number: JYY2023‐1
第一作者机构:[1]Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, 1 DongJiaoMinXiang, Beijing 100730, Peoples R China[2]Capital Med Univ, Beijing Inst Otolaryngol, Beijing Lab Allerg Dis, Beijing Municipal Educ Commiss,Minist Educ,Beijing, Beijing, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[1]Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, 1 DongJiaoMinXiang, Beijing 100730, Peoples R China[2]Capital Med Univ, Beijing Inst Otolaryngol, Beijing Lab Allerg Dis, Beijing Municipal Educ Commiss,Minist Educ,Beijing, Beijing, Peoples R China[3]Capital Med Univ, Beijing TongRen Hosp, Dept Allergy, Beijing, Peoples R China[*1]Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Dept Allergy, 1 Dong JiaoMin Xiang, Beijing 100730, Peoples R China
推荐引用方式(GB/T 7714):
Pan Sicen,Zhuang Mengyan,Wang Xiangdong,et al.Targeting PDK1: A novel approach to combat hypoxia-induced epithelial-mesenchymal transition in chronic rhinosinusitis with nasal polyps[J].CLINICAL AND TRANSLATIONAL ALLERGY.2025,15(4):doi:10.1002/clt2.70048.
APA:
Pan, Sicen,Zhuang, Mengyan,Wang, Xiangdong,Zhang, Qinqin,He, Ting...&Zhang, Luo.(2025).Targeting PDK1: A novel approach to combat hypoxia-induced epithelial-mesenchymal transition in chronic rhinosinusitis with nasal polyps.CLINICAL AND TRANSLATIONAL ALLERGY,15,(4)
MLA:
Pan, Sicen,et al."Targeting PDK1: A novel approach to combat hypoxia-induced epithelial-mesenchymal transition in chronic rhinosinusitis with nasal polyps".CLINICAL AND TRANSLATIONAL ALLERGY 15..4(2025)